Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Zeier

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|December 23, 2021
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 VaccinationLouise Benning, Christian Morath, Marie Bartenschlager, et al.
BMC Nephrology|September 21, 2018
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsClaudia Sommerer, Oliver Witzke, Frank Lehner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 6, 2025
Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function TrajectoriesLouise Benning, Marvin Reineke, Camila Eleuterio Rodrigues, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2014
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS studyFrank Lehner, Klemens Budde, Martin Zeier, et al.
Clinical Nephrology|March 3, 2016
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trialClaudia Sommerer, Klemens Budde, Martin Zeier, et al.
Medicine|March 10, 2020
Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant)Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, et al.
Annals of Human Genetics|September 13, 2011
Age-related penetrance of hereditary atypical hemolytic uremic syndromeMaren Sullivan, Lisa A Rybicki, Aurelia Winter, et al.
Frontiers in Immunology|September 28, 2020
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney TransplantationChristian Morath, Bernd Döhler, Florian Kälble, et al.
Nucleic Acids Research|October 5, 2017
Homeostatic nuclear RAGE-ATM interaction is essential for efficient DNA repairVarun Kumar, Thomas Fleming, Stefan Terjung, et al.
Ebiomedicine|June 23, 2016
Donor-specific antibodies require preactivated immune system to harm renal transplantCaner Süsal, Bernd Döhler, Andrea Ruhenstroth, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Clinical Journal of the American Society of Nephrology : CJASN|December 23, 2021
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 VaccinationLouise Benning, Christian Morath, Marie Bartenschlager, et al.
BMC Nephrology|September 21, 2018
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsClaudia Sommerer, Oliver Witzke, Frank Lehner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 6, 2025
Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function TrajectoriesLouise Benning, Marvin Reineke, Camila Eleuterio Rodrigues, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2014
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS studyFrank Lehner, Klemens Budde, Martin Zeier, et al.
Clinical Nephrology|March 3, 2016
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trialClaudia Sommerer, Klemens Budde, Martin Zeier, et al.
Medicine|March 10, 2020
Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant)Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, et al.
Annals of Human Genetics|September 13, 2011
Age-related penetrance of hereditary atypical hemolytic uremic syndromeMaren Sullivan, Lisa A Rybicki, Aurelia Winter, et al.
Frontiers in Immunology|September 28, 2020
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney TransplantationChristian Morath, Bernd Döhler, Florian Kälble, et al.
Nucleic Acids Research|October 5, 2017
Homeostatic nuclear RAGE-ATM interaction is essential for efficient DNA repairVarun Kumar, Thomas Fleming, Stefan Terjung, et al.
Ebiomedicine|June 23, 2016
Donor-specific antibodies require preactivated immune system to harm renal transplantCaner Süsal, Bernd Döhler, Andrea Ruhenstroth, et al.
Pageof 34